Literature DB >> 7531399

Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term.

D M Slater1, L C Berger, R Newton, G E Moore, P R Bennett.   

Abstract

OBJECTIVE: Our purpose was to compare the level of expression of both type 1 and type 2 cyclooxygenase genes before and after labor and to localize their expression within the fetal membranes. STUDY
DESIGN: The sites of type 2 and type 1 cyclooxygenase messenger ribonucleic acid synthesis were identified with in situ hybridization. Expression of both types 1 and 2 cyclooxygenase was studied by reverse transcriptase polymerase chain reaction.
RESULTS: Cyclooxygenase type 2 and type 1 expression was localized within the amniotic epithelium and amniotic mesoderm. Type 1 but not type 2 enzyme was also expressed in the chorionic mesoderm. Expression of the type 2 enzyme was significantly increased with the onset of labor. Type 1 enzyme expression did not significantly change with labor.
CONCLUSION: It is most likely that it is the inducible type 2 cyclooxygenase enzyme that mediates the increase in prostaglandin synthesis in amnion with the onset of labor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531399     DOI: 10.1016/0002-9378(95)90087-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

Review 1.  Management of preterm labour.

Authors:  S Vause; T Johnston
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

2.  Characterization of the transcriptome of chorioamniotic membranes at the site of rupture in spontaneous labor at term.

Authors:  Chia-Ling Nhan-Chang; Roberto Romero; Adi L Tarca; Pooja Mittal; Juan Pedro Kusanovic; Offer Erez; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; John Hotra; Nandor Gabor Than; Jung-Sun Kim; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

3.  Labor and inflammation increase the expression of oxytocin receptor in human amnion.

Authors:  Vasso Terzidou; Andrew M Blanks; Sung Hye Kim; Steven Thornton; Phillip R Bennett
Journal:  Biol Reprod       Date:  2010-10-06       Impact factor: 4.285

4.  The regulation of prostaglandin output from term intact fetal membranes by anti-inflammatory cytokines.

Authors:  N L Brown; S A Alvi; M G Elder; P R Bennett; M H Sullivan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

5.  Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract.

Authors:  Tae Young Oh; Gook Jun Ahn; Seul Min Choi; Byoung Ok Ahn; Won Bae Kim
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

6.  Calcium antagonistic properties of the cyclooxygenase-2 inhibitor nimesulide in human myometrial myocytes.

Authors:  G A Knock; P I Aaronson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

7.  Function of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxin.

Authors:  F Coceani; C Ackerley; E Seidlitz; L Kelsey
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

8.  Effect of propofol on prostaglandin E2 production and prostaglandin synthase-2 and cyclooxygenase-2 expressions in amniotic membrane cells.

Authors:  Ju Deok Kim; Byung Min Ahn; Bo Sun Joo; Jae Young Kwon; Hyung Joo Chung; Soo Bong Yu
Journal:  J Anesth       Date:  2014-04-22       Impact factor: 2.078

9.  Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

Authors:  B K Reuter; S Asfaha; A Buret; K A Sharkey; J L Wallace
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

10.  Umbilical cord prostaglandins in term and preterm parturition.

Authors:  Joon-Seok Hong; Roberto Romero; Deug-Chan Lee; Nandor Gabor Than; Lami Yeo; Piya Chaemsaithong; Soyeon Ahn; Jung-Sun Kim; Chong Jai Kim; Yeon Mee Kim
Journal:  J Matern Fetal Neonatal Med       Date:  2015-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.